106 related articles for article (PubMed ID: 27150632)
1. Epigenetic identification of ZNF545 as a functional tumor suppressor in multiple myeloma via activation of p53 signaling pathway.
Fan Y; Zhan Q; Xu H; Li L; Li C; Xiao Q; Xiang S; Hui T; Xiang T; Ren G
Biochem Biophys Res Commun; 2016 Jun; 474(4):660-666. PubMed ID: 27150632
[TBL] [Abstract][Full Text] [Related]
2. A novel 19q13 nucleolar zinc finger protein suppresses tumor cell growth through inhibiting ribosome biogenesis and inducing apoptosis but is frequently silenced in multiple carcinomas.
Cheng Y; Liang P; Geng H; Wang Z; Li L; Cheng SH; Ying J; Su X; Ng KM; Ng MH; Mok TS; Chan AT; Tao Q
Mol Cancer Res; 2012 Jul; 10(7):925-36. PubMed ID: 22679109
[TBL] [Abstract][Full Text] [Related]
3. Zinc-finger protein 545 inhibits cell proliferation as a tumor suppressor through inducing apoptosis and is disrupted by promoter methylation in breast cancer.
Xiao Y; Xiang T; Luo X; Li C; Li Q; Peng W; Li L; Li S; Wang Z; Tang L; Ren G; Tao Q
PLoS One; 2014; 9(10):e110990. PubMed ID: 25360542
[TBL] [Abstract][Full Text] [Related]
4. Zinc-finger protein 545 is inactivated due to promoter methylation and functions as a tumor suppressor through the Wnt/β-catenin, PI3K/AKT and MAPK/ERK signaling pathways in colorectal cancer.
Xiang S; Xiang T; Xiao Q; Li Y; Shao B; Luo T
Int J Oncol; 2017 Sep; 51(3):801-811. PubMed ID: 28677721
[TBL] [Abstract][Full Text] [Related]
5. Methylation-regulated ZNF545 inhibits growth of the p53-mutant KYSE150 cell line by inducing p21 and Bax.
Fan Y; Wang Y; Fu S; Liu D; Lin S
Exp Ther Med; 2019 Sep; 18(3):1563-1570. PubMed ID: 31410110
[TBL] [Abstract][Full Text] [Related]
6. Zinc-finger protein 545 is a novel tumour suppressor that acts by inhibiting ribosomal RNA transcription in gastric cancer.
Wang S; Cheng Y; Du W; Lu L; Zhou L; Wang H; Kang W; Li X; Tao Q; Sung JJ; Yu J
Gut; 2013 Jun; 62(6):833-41. PubMed ID: 22580414
[TBL] [Abstract][Full Text] [Related]
7. SOX30, a novel epigenetic silenced tumor suppressor, promotes tumor cell apoptosis by transcriptional activating p53 in lung cancer.
Han F; Liu W; Jiang X; Shi X; Yin L; Ao L; Cui Z; Li Y; Huang C; Cao J; Liu J
Oncogene; 2015 Aug; 34(33):4391-402. PubMed ID: 25435374
[TBL] [Abstract][Full Text] [Related]
8. The role of MIR-186 and ZNF545 in inhibiting the proliferation of multiple myeloma cells.
Deng S; Xiang JJ; Ge HP; Hu ZP; Shen JP; Lin SY; Zeng YQ
J Biol Regul Homeost Agents; 2019 May-Jun,; 33(3):721-729. PubMed ID: 31165610
[TBL] [Abstract][Full Text] [Related]
9. Poor survival is associated with the methylated degree of zinc-finger protein 545 (ZNF545) DNA promoter in gastric cancer.
Deng J; Liang H; Ying G; Dong Q; Zhang R; Yu J; Fan D; Hao X
Oncotarget; 2015 Feb; 6(6):4482-95. PubMed ID: 25714013
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.
Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ
Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic dysregulation of the death-associated protein kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in multiple myeloma.
Chim CS; Liang R; Fung TK; Choi CL; Kwong YL
J Clin Pathol; 2007 Jun; 60(6):664-9. PubMed ID: 17557868
[TBL] [Abstract][Full Text] [Related]
12. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
13. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
14. Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression.
De Smedt E; Maes K; Verhulst S; Lui H; Kassambara A; Maes A; Robert N; Heirman C; Cakana A; Hose D; Breckpot K; van Grunsven LA; De Veirman K; Menu E; Vanderkerken K; Moreaux J; De Bruyne E
Cancer Res; 2018 Mar; 78(5):1155-1168. PubMed ID: 29259009
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
[TBL] [Abstract][Full Text] [Related]
16. A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells.
Leotta M; Biamonte L; Raimondi L; Ronchetti D; Di Martino MT; Botta C; Leone E; Pitari MR; Neri A; Giordano A; Tagliaferri P; Tassone P; Amodio N
J Cell Physiol; 2014 Dec; 229(12):2106-16. PubMed ID: 24819167
[TBL] [Abstract][Full Text] [Related]
17. Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple Myeloma.
Sagawa M; Ohguchi H; Harada T; Samur MK; Tai YT; Munshi NC; Kizaki M; Hideshima T; Anderson KC
Clin Cancer Res; 2017 Sep; 23(17):5225-5237. PubMed ID: 28442502
[No Abstract] [Full Text] [Related]
18. Epigenetic silencing of LPP/miR-28 in multiple myeloma.
Li Z; Wong KY; Chan GC; Chim CS
J Clin Pathol; 2018 Mar; 71(3):253-258. PubMed ID: 28775176
[TBL] [Abstract][Full Text] [Related]
19. Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma.
Wilop S; van Gemmeren TB; Lentjes MH; van Engeland M; Herman JG; Brümmendorf TH; Jost E; Galm O
Epigenetics; 2011 Aug; 6(8):1047-52. PubMed ID: 21934357
[TBL] [Abstract][Full Text] [Related]
20. Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma.
Yeh CM; Chen PC; Hsieh HY; Jou YC; Lin CT; Tsai MH; Huang WY; Wang YT; Lin RI; Chen SS; Tung CL; Wu SF; Chang DC; Shen CH; Hsu CD; Chan MW
Oncotarget; 2015 Oct; 6(30):29555-72. PubMed ID: 26320192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
